New Course: The FDA and Prescription Drugs: Current Controversies in Context
This free, self-paced, six-session online course will cover pharmaceutical product development, approval, marketing, and costs, as well as an overview of FDA and the major issues affecting regulatory approval and evidence-based use of prescription drugs. For more information on the course material, watch this introductory video here. The course is run by the Program on Regulation, Therapeutics, and Law (PORTAL), a CRS partner program, in conjunction with HarvardX/edX, and begins on March 26. Register here!